Margie L. Traylor - 03 Mar 2022 Form 4 Insider Report for Augmedix, Inc.

Role
Director
Signature
/s/ Margie L. Traylor
Issuer symbol
N/A
Transactions as of
03 Mar 2022
Net transactions value
$0
Form type
4
Filing time
07 Mar 2022, 19:08:49 UTC
Previous filing
29 Nov 2021
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Employee Stock Option (right to buy) Award $0 +10,182 $0.000000 10,182 03 Mar 2022 Common Stock 10,182 $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. The option will vest monthly in equal increments for three months, subject to the Reporting Person's provision of service to the Issuer on each vesting date, and will be fully vested on May 27, 2022.